β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues

被引:69
作者
Hager, Marlies V. [1 ]
Johnson, Lisa M. [1 ,2 ,3 ,4 ]
Wootten, Denise [2 ,3 ]
Sexton, Patrick M. [2 ,3 ]
Gellman, Samuel H. [1 ]
机构
[1] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA
[2] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[3] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia
[4] Lab Med & Pathol, Mayo Mem Bldg,420 Delaware St,SE, Minneapolis, MN 55455 USA
基金
英国医学研究理事会;
关键词
GLUCAGON-LIKE PEPTIDE-1; 2ND EXTRACELLULAR LOOP; INSULIN-SECRETION; OXYNTOMODULIN; RECRUITMENT; ACTIVATION; BINDING; REGION;
D O I
10.1021/jacs.6b08323
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Activation of a G protein-coupled receptor (GPCR) causes recruitment of multiple intracellular proteins, each of which can activate distinct signaling pathways. This complexity has engendered interest in agonists that preferentially stimulate subsets among the natural signaling pathways ("biased agonists"). We have examined analogues of glucagon-like peptide-1 (GLP-1) containing beta-amino acid residues in place of native alpha residues at selected sites and found that some analogues differ from GLP-1 in terms of their relative abilities to promote G protein activation (as monitored via cAMP production) versus beta-arrestin recruitment (as monitored via BRET assays). The alpha -> beta replacements generally cause modest declines in stimulation of cAMP production and beta-arrestin recruitment, but for some replacement sets cAMP production is more strongly affected than is beta-arrestin recruitment. The central portion of GLP-1 appears to be critical for achieving bias toward beta-arrestin recruitment. These results suggest that backbone modification via alpha -> beta residue replacement may be a versatile source of agonists with biased GLP-1R activation profiles.
引用
收藏
页码:14970 / 14979
页数:10
相关论文
共 48 条
  • [1] Emergent biological properties of arrestin pathway-selective biased agonism
    Appleton, Kathryn M.
    Luttrell, Louis M.
    [J]. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2013, 33 (03) : 153 - 161
  • [2] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [3] Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure
    Baggio, LL
    Huang, QL
    Brown, TJ
    Drucker, DJ
    [J]. GASTROENTEROLOGY, 2004, 127 (02) : 546 - 558
  • [4] A new GLP-1 analogue with prolonged glucose-lowering activity in vivo via backbone-based modification at the N-terminus
    Bai, Xiaohui
    Niu, Youhong
    Zhu, Jingjing
    Yang, An-Qi
    Wu, Yan-Fen
    Ye, Xin-Shan
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (06) : 1163 - 1170
  • [5] A Luminescent Biosensor with Increased Dynamic Range for Intracellular cAMP
    Binkowski, Brock F.
    Butler, Braeden L.
    Stecha, Peter F.
    Eggers, Christopher T.
    Otto, Paul
    Zimmerman, Kris
    Vidugiris, Gediminas
    Wood, Monika G.
    Encell, Lance P.
    Fan, Frank
    Wood, Keith V.
    [J]. ACS CHEMICAL BIOLOGY, 2011, 6 (11) : 1193 - 1197
  • [6] OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM
    BLACK, JW
    LEFF, P
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219): : 141 - 162
  • [7] Optical Control of Insulin Secretion Using an Incretin Switch
    Broichhagen, Johannes
    Podewin, Tom
    Meyer-Berg, Helena
    von Ohlen, Yorrick
    Johnston, Natalie R.
    Jones, Ben J.
    Bloom, Stephen R.
    Rutter, Guy A.
    Hoffmann-Roeder, Anja
    Hodson, David J.
    Trauner, Dirk
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (51) : 15565 - 15569
  • [8] Actions of the Small Molecule Ligands SW106 and AH-3960 on the Type-1 Parathyroid Hormone Receptor
    Carter, Percy H.
    Dean, Thomas
    Bhayana, Brijesh
    Khatri, Ashok
    Rajur, Raj
    Gardella, Thomas J.
    [J]. MOLECULAR ENDOCRINOLOGY, 2015, 29 (02) : 307 - 321
  • [9] Backbone modification of a polypeptide drug alters duration of action in vivo
    Cheloha, Ross W.
    Maeda, Akira
    Dean, Thomas
    Gardella, Thomas J.
    Gellman, Samuel H.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (07) : 653 - +
  • [10] Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production
    de Menthière, CS
    Chavanieu, A
    Grassy, G
    Dalle, S
    Salazar, G
    Kervran, A
    Pfeiffer, B
    Renard, P
    Delagrange, P
    Manechez, D
    Bakes, D
    Ktorza, A
    Calas, B
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (06) : 473 - 480